🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to examine the safety and efficacy of the frui...
Status
Suspended
Location
Austin Health, Aged Care Services, Medical and Cognitive Research Unit
Start Date
2010-01
Trial ID
NCT00933348
Vitamin D(Vit D) is a pro-differentiation agent that enhances the accumulat...
Status
Completed
Location
Dong-A University
Start Date
2014-05
Trial ID
NCT02976727
The investigators' hypotheses are: Low-dose testosterone augmentation impro...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-08
Trial ID
NCT01783574
Treatments Being Tested
The purpose of this study is to determine if 0.5% Ivermectin Cream is a saf...
Status
Completed
Location
Arkansas Pediatric Clinic
Start Date
2010-03
Trial ID
NCT01068158
Treatments Being Tested
The purpose of this study is to clinically evaluate the efficacy, safety as...
Status
Completed
Location
University of California Davis
Start Date
2014-10
Trial ID
NCT02601105
Treatments Being Tested
This is a phase 2 study to investigate the safety and efficacy of PAC-14028...
Status
Completed
Location
Chung-ang University Hospital
Start Date
2015-10
Trial ID
NCT02757729
Treatments Being Tested
This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-...
Status
Unknown
Location
Ha'Emek MC
Start Date
2019-12-29
Trial ID
NCT04307862
Treatments Being Tested
This is a phase 2 randomized controlled trial testing the effect of topical...
Status
Completed
Location
Henry Ford Hospital
Start Date
2017-12-20
Trial ID
NCT03223350
Treatments Being Tested
The purpose of this first in human and proof of concept study is to charact...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2017-12-15
Trial ID
NCT03333694
Treatments Being Tested
To demonstrate therapeutic equivalence and safety of Trifarotene cream 0.00...
Status
Completed
Location
Taro Pharmaceuticals USA Inc.
Start Date
2023-02-22
Trial ID
NCT06063473
Treatments Being Tested